Anzeige
Mehr »
Login
Samstag, 19.04.2025 Börsentäglich über 12.000 News von 690 internationalen Medien
Gold auf 4.000 USD? Goldman Sachs sagen Ja - und bei Forge sitzt der Ex-CFO von Newmont mit am Tisch
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PGFW | ISIN: CNE100003F01 | Ticker-Symbol: CJH
Tradegate
17.04.25
16:48 Uhr
3,190 Euro
-0,088
-2,68 %
Branche
Biotechnologie
Aktienmarkt
ASIEN
1-Jahres-Chart
CANSINO BIOLOGICS INC Chart 1 Jahr
5-Tage-Chart
CANSINO BIOLOGICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
3,2663,35217.04.
3,1923,36817.04.

Aktuelle News zur CANSINO BIOLOGICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiCANSINOBIO (06185): LETTER TO NON-REGISTERED SHAREHOLDERS - REMINDER LETTER REGARDING THE ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS ...-
MiCANSINOBIO (06185): LETTER TO REGISTERED SHAREHOLDERS - REMINDER LETTER REGARDING THE ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS ...-
MiCANSINOBIO (06185): 2024 ENVIRONMENTAL, SOCIAL AND GOVERNANCE & CORPORATE SOCIAL RESPONSIBILITY REPORT-
MiCANSINOBIO (06185): 2024 ANNUAL REPORT1
CANSINO BIOLOGICS Aktie jetzt für 0€ handeln
DiCANSINOBIO (06185): NOTICE OF BOARD MEETING1
25.03.CanSino Biologics Inc: Revenue Soars with 137% Year-on-Year Growth, Multiple Products Poised for Launch, CanSinoBIO's Growth Momentum Strong204HONG KONG, Mar 25, 2025 - (ACN Newswire) - CanSino Biologics Inc. (Stock Code: 688185.SH, 6185.HK, 'CanSinoBIO' or the 'Company'), a leading player in China's vaccine industry, achieved significant...
► Artikel lesen
25.03.CANSINOBIO (06185): ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024-
12.03.CANSINOBIO (06185): NOTICE OF BOARD MEETING4
27.02.CANSINOBIO (06185): INSIDE INFORMATION - UPDATES ON 2024 PRELIMINARY ANNUAL RESULTS4
24.02.CANSINOBIO (06185): VOLUNTARY ANNOUNCEMENT - DTCP-HIB-MCV4 COMBINED VACCINE OBTAINS CLINICAL TRIAL APPROVAL IN CHINA14
17.02.CanSinoBIO to Showcase China's Vaccine Innovation at 2025 World Government Summit in Dubai315DUBAI, UAE, Feb. 17, 2025 /PRNewswire/ -- CanSino Biologics Inc. (CanSinoBIO or the Company), a leading Chinese vaccine innovator, has been invited to the 2025 World Government Summit in...
► Artikel lesen
07.02.CANSINOBIO (06185): VOLUNTARY ANNOUNCEMENT - THE CENTER FOR DRUG EVALUATION, NMPA GRANTED PRIORITY REVIEW STATUS TO NDA FOR DTCP INFANT4
06.02.CANSINOBIO (06185): VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF NEW DRUG APPLICATION FOR TETANUS VACCINE6
17.01.CANSINOBIO (06185): INSIDE INFORMATION - RESULTS FORECAST FOR THE YEAR 20249
30.12.24CANSINOBIO (06185): VOLUNTARY ANNOUNCEMENT - MENHYCIA OBTAINS DRUG REGISTRATION CERTIFICATE IN INDONESIA1
20.12.24CANSINOBIO (06185): VOLUNTARY ANNOUNCEMENT - INITIATION OF PHASE I/II CLINICAL TRIAL AND COMPLETION OF FIRST PATIENT ENROLLMENT IN PHASE I CLINICAL TRIAL ...-
20.12.24CANSINOBIO (06185): VOLUNTARY ANNOUNCEMENT - INITIATION OF PHASE II/III CLINICAL TRIAL AND COMPLETION OF FIRST PATIENT ENROLLMENT IN PHASE II CLINICAL ...4
16.12.24CANSINOBIO (06185): VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF NEW DRUG APPLICATION FOR DTCP INFANT1
13.12.24CANSINOBIO (06185): INSIDE INFORMATION - CHANGE OF INTERESTS OF PARTIES ACTING IN CONCERT1
26.11.24CANSINOBIO (06185): VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF THE SUPPLEMENTAL DRUG APPLICATION FOR MENHYCIA10
Seite:  Weiter >>
26 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1